The UK Center of Excellence in Regulatory Science and Innovation in Pharmacogenomics (UK CERSI-PGx), led by the University of Liverpool, has published its first clinical guideline focused on the use ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...

New guidelines and advocacy enhance myasthenia gravis treatment access, promoting proactive management and improved insurance coverage for diverse patient populations. There are key systemic factors ...

Guidelines should be used to aid treatment decisions, and treatment should be dictated by patient factors rather than by the preferences of individual teams. Patients should be made aware of the ...